New onset atrial fibrillation after initiating amphetamine-dextroamphetamine therapy for ADHD: A case report

Abstract

Atrial fibrillation is a common arrhythmia in the general population, and is expected to significantly increase in prevalencein the near future. This case illustrates a 50-year-old male who developed atrial fibrillation after starting amphetaminedextroamphetaminefor attention deficit hyperactivity disorder (ADHD), with no previous history of structural heart disease. Central nervous system stimulant medications have significant cardiovascular implications and at risk patients should be monitoredclosely. Additionally, identifying causative agents for atrial fibrillation and other arrhythmias is imperative, as there is a significantassociation with morbidity and mortality.